Acta anaesthesiologica Scandinavica
-
Acta Anaesthesiol Scand · May 2022
Randomized Controlled TrialAuraGain™ versus i-gel™ for Bronchoscopic Intubation under Continuous Oxygenation: a Randomised Controlled Trial.
After failed mask ventilation and tracheal intubation, guidelines issued by the Difficult Airway Society recommend placing a second generation supraglottic airway device to secure oxygenation. Ultimately, a secure airway can be obtained by tracheal intubation through the supraglottic airway device using a bronchoscope. In this randomised trial, we compared the AuraGain™ with the i-gel™ as conduit for bronchoscopic intubation under continuous oxygenation performed by a group of anaesthesiologists with variable experience in a general population of patients. ⋯ We found no difference in total time for airway management between using the i-gel™ and using the AuraGain™.